Currency In USD
| Previous Close | 2.64 |
| Open | 2.55 |
| Day High | 2.69 |
| Day Low | 2.3 |
| 52-Week High | 15.15 |
| 52-Week Low | 2.33 |
| Volume | 131,904 |
| Average Volume | 129,772 |
| Market Cap | 3.11M |
| PE | -0.8 |
| EPS | -2.92 |
| Moving Average 50 Days | 4.38 |
| Moving Average 200 Days | 4.05 |
| Change | -0.3 |
Data not available
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
GlobeNewswire Inc.
Jun 27, 2025 8:05 PM GMT
NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
GlobeNewswire Inc.
Jun 03, 2025 12:45 PM GMT
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“SEC”) of a registration state
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
GlobeNewswire Inc.
Apr 11, 2025 8:15 PM GMT
NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C